Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's After-Market Session

Author: Benzinga Insights | December 13, 2023 05:31pm

Gainers

  • OneMedNet (NASDAQ:ONMD) shares increased by 25.6% to $1.08 during Wednesday's after-market session. The market value of their outstanding shares is at $34.8 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares moved upwards by 10.14% to $3.04. The market value of their outstanding shares is at $2.1 million.
  • Codexis (NASDAQ:CDXS) shares increased by 10.04% to $2.3. The market value of their outstanding shares is at $160.6 million.
  • NuCana (NASDAQ:NCNA) shares moved upwards by 8.5% to $0.37. The market value of their outstanding shares is at $19.5 million.
  • Avalo Therapeutics (NASDAQ:AVTX) shares rose 8.47% to $0.06. The market value of their outstanding shares is at $12.3 million.
  • Pieris Pharmaceuticals (NASDAQ:PIRS) shares increased by 6.49% to $0.15. The market value of their outstanding shares is at $14.7 million.

Losers

  • Monte Rosa Therapeutics (NASDAQ:GLUE) shares decreased by 16.2% to $4.18 during Wednesday's after-market session. The market value of their outstanding shares is at $209.3 million.
  • MorphoSys (NASDAQ:MOR) stock fell 15.43% to $8.06. The market value of their outstanding shares is at $1.1 billion.
  • Ocular Therapeutix (NASDAQ:OCUL) shares fell 14.22% to $3.38. The company's market cap stands at $268.4 million.
  • Assure Hldgs (NASDAQ:IONM) stock decreased by 13.84% to $0.35. The company's market cap stands at $2.3 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) shares fell 10.01% to $0.05. The market value of their outstanding shares is at $12.3 million.
  • Candel Therapeutics (NASDAQ:CADL) shares fell 7.57% to $1.1. The market value of their outstanding shares is at $31.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVTX BDRX CADL CDXS GLUE IONM MOR NCNA OCUL ONMD PIRS TCRT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist